NFKB1 and diffuse large B-cell lymphoma: Regarding of the participation of NF-κB in many cell processes like tumor proliferation, invasion and inflammation, targeting NF-κB pathway has become one of the promising therapeutic approach in ABC-DLBCL treatment [5].